BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 8992870)

  • 1. Hypertrophic cardiomyopathy in Noonan syndrome.
    Nishikawa T; Ishiyama S; Shimojo T; Takeda K; Kasajima T; Momma K
    Acta Paediatr Jpn; 1996 Feb; 38(1):91-8. PubMed ID: 8992870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noonan syndrome: a clinical description emphasizing the cardiac findings.
    Noonan J; O'Connor W
    Acta Paediatr Jpn; 1996 Feb; 38(1):76-83. PubMed ID: 8992867
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular abnormalities in Noonan syndrome: the clinical findings and treatments.
    Ishizawa A; Oho S; Dodo H; Katori T; Homma SI
    Acta Paediatr Jpn; 1996 Feb; 38(1):84-90. PubMed ID: 8992869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical, severe hypertrophic cardiomyopathy in a newborn presenting Noonan syndrome harboring a recurrent heterozygous MRAS variant.
    Pires LVL; Bordim RA; Maciel MBR; Tanaka ACS; Yamamoto GL; Honjo RS; Kim CA; Bertola DR
    Am J Med Genet A; 2021 Oct; 185(10):3099-3103. PubMed ID: 34080768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual combination of congenital heart defects in an infant with Noonan syndrome.
    Feit LR; Hansen K; Oyer CE; Werner JC
    Pediatr Cardiol; 1995; 16(2):95-9. PubMed ID: 7784245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noonan Syndrome Case Report: PTPN11 and Other Potential Genetic Factors Contributing to Lethal Hypertrophic Right Ventricular Cardiomyopathy.
    Daoud E; Zwick D
    Pediatr Dev Pathol; 2019; 22(4):386-390. PubMed ID: 30665336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restrictive and hypertrophic cardiomyopathies in Noonan syndrome: the overlap syndromes.
    Wilmshurst PT; Katritsis D
    Heart; 1996 Jan; 75(1):94-7. PubMed ID: 8624883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
    Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
    Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry.
    Wilkinson JD; Lowe AM; Salbert BA; Sleeper LA; Colan SD; Cox GF; Towbin JA; Connuck DM; Messere JE; Lipshultz SE
    Am Heart J; 2012 Sep; 164(3):442-8. PubMed ID: 22980313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.
    Jaffré F; Miller CL; Schänzer A; Evans T; Roberts AE; Hahn A; Kontaridis MI
    Circulation; 2019 Jul; 140(3):207-224. PubMed ID: 31163979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival implications: hypertrophic cardiomyopathy in Noonan syndrome.
    Hickey EJ; Mehta R; Elmi M; Asoh K; McCrindle BW; Williams WG; Manlhiot C; Benson L
    Congenit Heart Dis; 2011; 6(1):41-7. PubMed ID: 21269411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
    Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
    Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes.
    Cerrato F; Pacileo G; Limongelli G; Gagliardi MG; Santoro G; Digilio MC; Di Salvo G; Ardorisio R; Miele T; Calabrò R
    Cardiol Young; 2008 Dec; 18(6):575-80. PubMed ID: 18842161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results.
    Calcagni G; Limongelli G; D'Ambrosio A; Gesualdo F; Digilio MC; Baban A; Albanese SB; Versacci P; De Luca E; Ferrero GB; Baldassarre G; Agnoletti G; Banaudi E; Marek J; Kaski JP; Tuo G; Russo MG; Pacileo G; Milanesi O; Messina D; Marasini M; Cairello F; Formigari R; Brighenti M; Dallapiccola B; Tartaglia M; Marino B
    Int J Cardiol; 2017 Oct; 245():92-98. PubMed ID: 28768581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type.
    Tsuda E; Ito Y; Kato Y; Sakaguchi H; Ohuchi H; Kurosaki K
    J Cardiol; 2022 Dec; 80(6):557-562. PubMed ID: 35961804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort.
    Chen H; Li X; Liu X; Wang J; Zhang Z; Wu J; Huang M; Guo Y; Li F; Wang X; Fu L
    Orphanet J Rare Dis; 2019 Feb; 14(1):29. PubMed ID: 30732632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic Screening Using Patient-Derived Induced Pluripotent Stem Cells Identified Pyr3 as a Candidate Compound for the Treatment of Infantile Hypertrophic Cardiomyopathy.
    Sakai T; Naito AT; Kuramoto Y; Ito M; Okada K; Higo T; Nakagawa A; Shibamoto M; Yamaguchi T; Sumida T; Nomura S; Umezawa A; Miyagawa S; Sawa Y; Morita H; Lee JK; Shiojima I; Sakata Y; Komuro I
    Int Heart J; 2018 Sep; 59(5):1096-1105. PubMed ID: 30101858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAF1 mutation leading to hypertrophic cardiomyopathy in a Chinese family with a history of sudden cardiac death: A diagnostic insight into Noonan syndrome.
    Zheng J; Peng L; Cheng R; Li Z; Xie J; Huang E; Cheng J; Zhao Q
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2290. PubMed ID: 37787490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral coronary artery dilatation and supravalvular pulmonary stenosis in a child with noonan syndrome.
    Uçar T; Atalay S; Tekin M; Tutar E
    Pediatr Cardiol; 2005; 26(6):848-50. PubMed ID: 16088418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.